From: Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer biomarkers
Estrogen Metabolite as Potential Biomarker | Biofluids | Level in the Endometrial Cancer Cases Compared with the Controls | References |
---|---|---|---|
Estrone | Serum | ↑ or ↔ | 13,16,17,21,36 |
Estradiol | Serum | ↑ | 13,16,17,21,36 |
Urine | ↑ | 14 | |
2-Hydroxyestrone | Serum | ↑ | 36, 37 |
Urine | ↔ | 14 | |
2-Hydroxyestradiol | Serum | ↑ or ↔ | 36, 37 |
Urine | ↔ | 14 | |
2-Methoxyestrone | Serum | ↔ | 36, 37 |
Urine | ↓ | 14 | |
2-Methoxyestradiol | Serum | ↔ | 36, 37 |
Urine | ↓ | 14 | |
4-Hydroxyestrone | Serum | ↑ | 36, 37 |
Urine | ↔ | 14 | |
4-Hydroxyestradiol | Serum | ↑ | 36, 37 |
Urine | ↑ | 14 | |
4-Methoxyestrone | Serum | ↔ | 36, 37 |
4-Methoxyestradiol | Serum | ↔ | 36, 37 |
16alpha-Hydroxyestrone | Serum | ↑ | 36, 38 |
Urine | ↔ | 14 | |
Estriol | Serum | ↑ or ↔ | 37 |